Stay updated on Fisogatinib in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page
- CheckyesterdayChange DetectedUpdated revision from v3.0.1 to v3.0.2, indicating a new release with potential fixes or improvements. The Back to Top element was removed, a minor navigation change.SummaryDifference0.2%
- Check8 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check16 days agoChange DetectedThe web page has updated its facility name and location details, specifically clarifying the geographic context by replacing 'Korea, Republic of' with 'South Korea' and providing more precise postal codes. Additionally, it has introduced new medical topics related to liver cancer and liver diseases.SummaryDifference6%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Fisogatinib in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fisogatinib in Hepatocellular Carcinoma Clinical Trial page.